Ziyad Al-Aly, MD @zalaly · 04 May 2026
At 3 years, NAION was more frequent among people who started GLP-1 drugs: ▸ GLP-1 drugs: 39.1 cases per 10,000 persons ▸ SGLT2 inhibitors: 29.3 cases per 10,000 persons That works out to 6 to 10 extra cases per 10,000. A 35% higher risk on GLP-1. https://t.co/RnayJqA972
5 592Views
29Likes
7Reposts
6Replies
0Quotes
17Bookmarks
Is that a lot?
4.04×vs 10K–100K median1 384 views is typical
17.58%Reachviews ÷ followers
0.75%Engagement rateof viewers reacted